Core Viewpoint - Ailong Technology (688329) reported a revenue increase of 25.12% year-on-year for the first three quarters of 2025, indicating strong growth in the medical supplies management sector [2]. Financial Performance - For the first three quarters of 2025, Ailong Technology achieved a main business revenue of 280 million yuan, with a net profit attributable to shareholders of -959,000 yuan, an improvement of 96.56% year-on-year [2]. - The third quarter of 2025 saw a single-quarter main business revenue of 149 million yuan, reflecting an 83.53% year-on-year increase, and a net profit attributable to shareholders of 7.43 million yuan, up 182.09% year-on-year [2]. - The company reported a gross profit margin of 45.79% and a debt ratio of 42.74% [2]. Market Activity - As of January 28, 2026, Ailong Technology's stock closed at 24.27 yuan, down 0.37%, with a turnover rate of 1.53% and a trading volume of 11,800 hands, amounting to a transaction value of 28.73 million yuan [1]. - The net outflow of main funds was 1.0035 million yuan, accounting for 3.49% of the total transaction value, while retail investors saw a net inflow of 3.43 million yuan, representing 11.94% of the total transaction value [1].
股票行情快报:艾隆科技(688329)1月28日主力资金净卖出100.35万元